Abstract
The epidemiology and clinical outcome of multiple myeloma in human immunodeficiency virus (HIV)-positive patients is poorly documented. There are uncertainties concerning the optimal management of this rare disorder. We report on the use of myeloablative chemotherapy with autologous stem cell transplantation in an HIV-positive patient with multiple myeloma.
Bone Marrow Transplantation (2002) 29, 273–275. doi:10.1038/sj.bmt.1703348
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kaplan MH, Susin M, Pahwa SG et al. Neoplastic complications of HTLV-III infection Am J Med 1987 82: 389 396
Kumar S, Kumar D, Schnadig VJ et al. Plasma cell myeloma in patients who are HIV-positive Am J Clin Pathol 1994 102: 633 639
Grulich AE, Wan X, Law MG et al. Risk of cancer in people with AIDS AIDS 1999 13: 839 843
Rabkin CS . Association of non-acquired immunodeficiency syndrome-defining cancers with human immunodeficiency virus infection Monogr Natl Cancer Inst 1998 23: 23 25
Tirelli U, Vaccher E, Zagonel V et al. Malignant tumors other than lymphomas and Kaposi's sarcoma in association with HIV infection Cancer Detect Prevent 1988 12: 267 272
Bladé J, Kyle RA . Multiple myeloma in young patients: clinical presentation and treatment approach Leuk Lymphoma 1998 30: 493 501
Fiorino AS, Atac B . Paraproteinemia, plasmacytoma, myeloma and HIV infection Leukemia 1997 11: 2150 2156
Herranz S, Sala M, Cervantes M et al. Neoplasia of plasma cells with atypical presentation and infection by the human immunodeficiency virus. A presentation of two cases Am J Hematol 2000 65: 239 242
Heuberger L, Costello RT, Petit N et al. First case of plasma-cell leukemia co-existing with human immunodeficiency virus infection Leukemia 1998 12: 103 104
Smith ML, Newland AC . Treatment of myeloma QJ Med 1999 92: 11 14
Attal M, Harousseau JL, Stoppa A et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma New Engl J Med 1996 335: 91 97
Gabarre J, Azar N, Autran B et al. High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1 associated lymphoma Lancet 2000 355: 1071 1072
Molina A, Krishnan AY, Nadamanee A et al. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy Cancer 2000 89: 680 689
Schneider E, Lambermont M, Van Vooren JP et al. Autologous stem cell infusion for acute myeloblastic leukemia in an HIV-1 carrier Bone Marrow Transplant 1997 20: 611 612
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kentos, A., Vekemans, M., Van Vooren, J. et al. High-dose chemotherapy and autologous CD34-positive blood stem cell transplantation for multiple myeloma in an HIV carrier. Bone Marrow Transplant 29, 273–275 (2002). https://doi.org/10.1038/sj.bmt.1703348
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703348
Keywords
This article is cited by
-
Plasma cell disorders in HIV-infected patients: epidemiology and molecular mechanisms
Biomarker Research (2013)